Did you know that oat beta glucan has enjoyed a long history as a special fiber for heart health?
The Beta Glucan Synbiotic is qualified for the American Heart Association “Healthy Heart” seal of approval.
From Sharper & Jones in 1959, to the Cornell China study in 1998, Andersson & Hellstrand in 2012, and the NIH report in 2015: oat beta glucan is found to lower LDL cholesterol and support a healthy heart function.
According to Andersson & Hellstrand (2012), oat β-glucan is not only known for its ability to lower LDL, but also for the general cardiovascular health-promoting properties – the micronutrients of oats, phytonutrients, that contribute to the protection of our hearts.
To strengthen the heart health properties, the Beta Glucan Synbiotic also contains red beetroot, shown in research as a rich source of dietary nitrate for heart and vascular health.
The gastrointestinal is central to a healthy functioning heart (Kassaian et al., 2017; Sáez-Lara et al., 2016), with many researchers positing the connection between heart and gut health (Serino et al., 2014; Huang et al., 2013).
The Beta Glucan is a comprehensive, multifunctional product – formulated to nourish the heart, open up circulation, and create a balanced microbiota in the gut.*
- Anderson, K.E., & Hellstrand, P. (2012). Dietary oats and modulation of atherogenic pathways. Mol Nutr Food Res, 56(7), 1003-13.
- Campbell T.C., Parpia, B., & Chen, J. (1998). Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study.Am J Cardio, 82(10B), 18T-21T. Abstract
- Huang, Y., Wang, X., Wang, J., Wu, F., Sui, Y., Yang, L., Wang, Z. (2013). Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity. J Dairy Sci, 96(5), 2746-53
- Kassaian, N., Aminorroaya, A., Feizi, A., Jafari, P., Amini, M. (2017). The effects of probiotic and synbiotic supplementation on metabolic syndrome indices in adults at risk of type 2 diabetes: study protocol for a randomized controlled trial. Trial, 18(1), 148. DOI: 10.1186/s13063-017-1885-8
- NIH (2015). Coronary Heart Disease. National Heart, lung, and Blood Institute; nhibi.hih.gov/health-topics/cad.
- Sáez-Lara, M.J., Robles-Sanchez, C., Ruiz-Ojeda, F.J., Plaza-Diaz, J., Gil, A.(2016). Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. Int J Mol Sci, 17(6).
- Serino, M., Blasco-Baque, V., Nicolas, S., & Burcelin, R. (2014). Far from the Eyes, Close to the Heart: Dysbiosis of Gut Microbiota and Cardiovasuclar Consequences. Curr Cardiol Rep, 16(11), 540.
- Shaper, A.G., & Jones, K.W. (1959). Serum-cholesterol, diet, and coronary heart disease in Africans, and Asians in Uganda.The Lancet, 275(7102), 534-37.
To your health,
We have developed our products based on scientific research and/or the practical experience of many healthcare practitioners. There is a growing body of literature on food based nutrition and supplements and their application in support of our health. Please use our products under the advisement of your doctor.
The Game Changer, produced by James Cameron et al., is a revolutionary new documentary about meat, protein and strength.
It is an absolute must see. The link above will connect you to their home page.
©2005 – 2019 BioImmersion Inc. All Rights Reserved